[HTML][HTML] Bone mineral density in patients with idiopathic pulmonary fibrosis

K Ikezoe, T Handa, K Tanizawa, T Kubo, T Oguma… - Respiratory …, 2015 - Elsevier
Background Decreased bone mineral density (BMD) has been reported in patients with
interstitial lung disease. However, BMD has not been evaluated in steroid-naïve patients …

Accelerated loss of antigravity muscles is associated with mortality in patients with COPD

K Tanimura, S Sato, A Sato, N Tanabe, K Hasegawa… - Respiration, 2020 - karger.com
Background: Low antigravity muscle mass is strongly associated with poor prognosis in
patients with chronic obstructive pulmonary disease (COPD). However, the significance of …

[HTML][HTML] Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach

P Faverio, A Fumagalli, S Conti, F Madotto, F Bini… - Respiratory …, 2022 - Springer
Background Sarcopenia gained importance in the evaluation of patients with chronic
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …

The clinical significance of body weight loss in idiopathic pulmonary fibrosis patients

Y Nakatsuka, T Handa, M Kokosi, K Tanizawa… - Respiration, 2018 - karger.com
Background: The significance of the nutritional status in idiopathic pulmonary fibrosis (IPF) is
largely unknown. Temporal body weight (BW) change, a dynamic index of nutrition status …

[HTML][HTML] A systematic review of the prognostic significance of the body mass index in idiopathic pulmonary fibrosis

A Zinellu, C Carru, P Pirina, AG Fois… - Journal of Clinical …, 2023 - mdpi.com
The identification of novel prognostic biomarkers might enhance individualized
management strategies in patients with idiopathic pulmonary fibrosis (IPF). Although several …

Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, Y Mori… - Chronic Respiratory …, 2022 - journals.sagepub.com
Objectives Sarcopenia is a syndrome characterized by reduced muscle mass and function. It
is well-recognized as a complication in chronic diseases such as chronic obstructive …

[HTML][HTML] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC pulmonary …, 2022 - Springer
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …

Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis

TM Maher, S Stowasser, F Voss, E Bendstrup… - …, 2023 - Wiley Online Library
Abstract Background and Objective Surrogate endpoints enable determination of
meaningful treatment effects more efficiently than applying the endpoint of ultimate interest …

[HTML][HTML] Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis

T Bahmer, AM Kirsten, B Waschki, KF Rabe… - BMC pulmonary …, 2017 - Springer
Background Physical activity (PA) is associated with disease severity in idiopathic
pulmonary fibrosis (IPF), but longitudinal studies evaluating its prognostic value and …

Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction

R Teramachi, H Taniguchi, Y Kondoh, M Ando… - …, 2017 - Wiley Online Library
Background and objective Elevation of mean pulmonary arterial pressure (MPAP) is
associated with poor prognosis in patients with idiopathic pulmonary fibrosis (IPF), yet the …